If you have watched someone you love fall apart in the two weeks before her period — genuinely fall apart, not just be irritable — and then watched her come back to herself the moment menstruation began, you may have been living alongside PMDD without either of you knowing what it was.

This guide is not a clinical summary. It is a plain-language account of what PMDD is, what the science says about why it happens, and what the evidence — including research published specifically on partners — tells us about how to be useful rather than an additional source of pressure.

What is PMDD?

Premenstrual Dysphoric Disorder (PMDD) is a severe cyclical mood disorder characterised by significant psychological and physical symptoms that emerge during the luteal phase of the menstrual cycle — the two weeks between ovulation and the start of menstruation — and resolve within a day or two of menstruation beginning.

It has been a recognised diagnostic category in the DSM-5 since 2013, classified under depressive disorders, and in the ICD-11 as a gynaecological diagnosis — which reflects both its hormonal origin and its psychiatric impact.1 The dual classification is not a contradiction; it reflects the condition's genuine complexity.

How common is it? Multiple systematic reviews and meta-analyses place the confirmed prevalence of PMDD at 3–8% of women of reproductive age when assessed by symptom reporting, and 1.6–3.2% when confirmed using the gold-standard method of prospective daily symptom tracking across two or more cycles.2 The gap between reported and confirmed rates reflects how difficult the condition is to diagnose — not that the experience is less real for those in the higher estimate. IAPMD estimates this represents tens of millions of people worldwide.3

What causes it?

The most well-evidenced explanation centres on the brain's abnormal sensitivity to allopregnanolone — a neurosteroid produced as progesterone metabolises after ovulation. In most people, allopregnanolone acts as a positive modulator of GABA-A receptors, producing a calming effect. In women with PMDD, this normal process triggers dysregulated neurological responses instead, causing the cascade of mood and cognitive symptoms that define the condition.4

This is not a hormonal imbalance in the conventional sense. Hormone levels in women with PMDD are typically normal. The difference is in how the brain responds to those hormones — a distinction that matters because it explains why telling someone with PMDD to "balance her hormones" misses the point entirely. The issue is neurobiological sensitivity, not hormonal level.

Research also points to genetic factors: specific variations in GABA receptor genes have been linked to PMDD susceptibility,5 suggesting a heritable component. It is not caused by stress, diet, trauma, or relationship problems, though these factors can influence severity.

What does PMDD look like?

Symptoms typically emerge within a few days of ovulation and resolve within 24–48 hours of menstruation starting. That pattern — cyclical onset and offset aligned precisely with the menstrual cycle — is the defining diagnostic feature. If her experience fits the timing, the cause is likely hormonal.

Common symptoms include:

On suicidal ideation — what the research shows: The link between PMDD and suicidality is one of the most important and least discussed aspects of the condition. A large global study of 599 people with prospectively confirmed PMDD found that 72% reported lifetime active suicidal ideation, and 34% had made a suicide attempt.6 A separate study of 110 women with confirmed PMDD found that nearly 40% reported current suicidal ideation specifically during the late luteal phase — a rate comparable to that seen in major depressive disorder.7

These figures come from treatment-seeking populations, which tend toward higher severity. They are not general population estimates. But they are not outliers either — they are consistent across multiple studies, and IAPMD considers suicidality a core feature of severe PMDD that requires explicit clinical attention.3

If she has mentioned thoughts of suicide or self-harm during the luteal phase — even briefly, even once — take it seriously. It is a symptom of the condition, not a verdict on her life or your relationship. It is likely to ease when menstruation begins. That does not make it less urgent in the moment.

If she is in crisis right now: In the UK, call or text 116 123 (Samaritans, 24 hours, free). Text SHOUT to 85258 for a text-based crisis service. In the US, call or text 988 (Suicide and Crisis Lifeline). You do not need to wait for it to get worse before using these.

The diagnosis problem

The average time from first experiencing PMDD symptoms to receiving a correct diagnosis is around 12 years.8 During that period, many women are misdiagnosed with major depressive disorder, anxiety, borderline personality disorder, or bipolar disorder — conditions whose treatments do not address the hormonal mechanism at the root of PMDD, and which can make things worse.

Many see five or more different healthcare providers before receiving a diagnosis. IAPMD reports that over 75% cycle through multiple treatment options before finding even partial relief.3 The stigma attached to both menstruation and mental health makes it harder to seek help; dismissal from healthcare professionals — which is well-documented — makes it harder still.9

Understanding this matters for you. The woman in your life may have been fighting to be believed for years before you came along, or may still be fighting. Her frustration with the medical system is not irrational; it is the product of a system that has historically failed this condition.

The impact on partners — what the research actually says

Until recently, almost no research existed specifically on the partner experience of PMDD. That changed with a landmark 2025 study published in PLOS ONE — the first of its kind to examine the impact on both the person with PMDD and their partner.10

The findings are worth understanding directly. Partners of women with PMDD reported lower quality of life across most domains compared to partners of women without PMDD. They also reported lower relationship quality across almost every measure — lower trust, lower intimacy, lower passion, and lower overall relationship satisfaction. The one domain that held was love and commitment: partners remained committed even as the relationship was strained in other areas.

Partners also reported high levels of stress, a diminished sense of personal growth, and difficulties in their caregiving role. Critically, the study found that the "support for caring" domain — the extent to which partners themselves received practical or emotional support — scored in the low quality of life range. The support needs of PMDD partners are largely unmet, and the researchers noted this places partners at meaningful risk of developing mental health difficulties of their own.10

What this means for you: Your experience of loving someone with PMDD is not trivial. The research confirms it is hard. The emotional exhaustion, the confusion about what is a symptom and what is the relationship, the grief of losing her to the luteal phase every month — these are documented experiences shared by partners worldwide. You are not failing at something other people manage easily. You are navigating something genuinely difficult, with very little external support designed for your specific situation.

The cycle pattern — what to observe

PMDD follows the menstrual cycle with precision. Understanding the pattern does not give you control over it, but it gives you context — which is a different and more useful thing.

In a typical cycle, the first half (follicular phase, from menstruation to ovulation) is often composed of her better days. She is more like herself. Then ovulation occurs — usually somewhere around day 14 of a standard 28-day cycle, though this varies considerably — and within 24 to 48 hours the shift begins. The luteal phase that follows can range from difficult to genuinely devastating, depending on the cycle and her individual experience of the condition. Then her period starts, and within a day or two the symptoms ease. She comes back.

That return matters. When she is herself again after menstruation begins, that is not her recovering from a bad mood. It is the neurobiological mechanism resetting. The version of her that appears during a severe PMDD episode is not who she is — it is what the condition does to her brain when it is responding abnormally to allopregnanolone. Keeping hold of that distinction, especially in the hardest moments, is one of the most important things a partner can do.

What she needs from you — and what she does not

There is no single approach that works for every person with PMDD, and imposing one without asking is itself a form of not listening. What follows is grounded in what the evidence and the experience of PMDD communities consistently identifies — but the most important thing you can do is ask her directly what helps, and when.

She needs you to believe her. PMDD has been dismissed by GPs, family members, and partners for decades. The average 12-year path to diagnosis is built, in part, on disbelief. If she has told you this is PMDD, she has almost certainly done the work of tracking, researching, and fighting to be taken seriously. Believing her costs nothing. To her, it means a great deal.

She needs you to separate the condition from the relationship. Things said during a severe PMDD episode — about the relationship, about you, about herself — are often symptoms of the condition rather than considered reflections of how she feels. This does not mean her feelings are invalid, or that you absorb everything without limit. It means that conversations about what happened during a PMDD episode are usually better had after her period has started, when she has full access to herself. Timing matters.

She needs you to reduce friction without making it a performance. During the luteal phase, the ordinary load of daily life can feel insurmountable. Quietly handling things that are normally shared — cooking, logistics, decisions — without announcing why or expecting acknowledgement is one of the most consistently valued forms of support. It is useful precisely because it does not require anything from her.

She does not need you to manage the condition on her behalf. Checking in constantly, asking where she is in her cycle, pre-emptively adjusting your behaviour based on cycle day — however well-intentioned — can feel like monitoring rather than care. The goal is to be a steady, low-friction presence. Not a cycle-aware project manager.

She does not need you to fix it. PMDD is not fixable by a partner. Arriving with supplements, dietary protocols, or coping strategies she has not asked for, however lovingly offered, usually adds to the load rather than reducing it. If she wants your help researching treatment options, she will tell you.

Looking after yourself

The 2025 PLOS ONE study makes clear that partners of people with PMDD are a population with unmet support needs. Being the steady presence for someone with a severe cyclical condition — month after month, across years — is a genuine demand on your emotional and psychological resources. It is not sustainable to treat your own needs as secondary to hers indefinitely.

This means having people you can talk to about your experience honestly. It means not performing fine when you are not. It may mean therapy — individually, or as a couple with a therapist who understands PMDD specifically, which is a smaller group than it should be but does exist.

Supporting her well over the long term requires that you are also supported. These are not competing priorities.

PMDD and Yori

Yori supports PMDD as one of its six dedicated conditions. When a profile is set up with PMDD, the daily AI insights adapt to reflect the specific hormonal and neurobiological dynamics of each phase — including the luteal phase specifically, where the condition is most active. The goal is to give you grounding in what may be happening biologically, so that when a hard stretch comes, you have some context to hold onto.

Yori does not tell you what she is feeling. It will not predict her symptoms or tell you how severe a given cycle will be. What it can do is ensure that you are not navigating her experience entirely without reference points — which is where most partners start, and where misunderstanding tends to accumulate.

Built for partners of women with PMDD

Yori gives you daily, cycle-aware insights grounded in the science of her condition — not generic advice. Her participation is never required. Free on Android.

Download Yori on Android ↗

Sources & references

  1. 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 2013. PMDD classified under Depressive Disorders. See also: WHO ICD-11 classification GA34.41.
  2. 2. Reilly TJ, et al. The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis. Journal of Affective Disorders, 2024. Confirmed diagnosis prevalence 1.6% (community samples) to 3.2% (clinical). View paper ↗
  3. 3. International Association for Premenstrual Disorders (IAPMD). Facts & Figures. iapmd.org/facts-figures ↗
  4. 4. Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiology of Stress, 2020;12:100213. View paper ↗
  5. 5. Sun C, et al. Allopregnanolone-mediated GABAA-Rα4 function in amygdala and hippocampus of PMDD model rats. Aging, 2023. PMC10008490 ↗
  6. 6. Eisenlohr-Moul T, et al. Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients with prospectively confirmed PMDD. BMC Psychiatry, 2022. PMC8933886 ↗
  7. 7. Hantsoo L, et al. Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder. Journal of Affective Disorders, 2022. PMC8832802 ↗
  8. 8. The Pharmaceutical Journal / Royal College of Pharmacy. Premenstrual dysphoric disorder: recognition, management and treatment. December 2025. Average diagnosis delay: approximately 12 years. View article ↗
  9. 9. Osborn E, et al. Exploring diagnosis and treatment of premenstrual dysphoric disorder in the US healthcare system: a qualitative investigation. PMC, 2023. PMC10193729 ↗
  10. 10. Hodgetts S, et al. Examining the impact of premenstrual dysphoric disorder (PMDD) on life and relationship quality: An online cross-sectional survey study. PLOS ONE, April 2025. First study of its kind examining partner quality of life. View paper ↗

This article was researched and written with AI assistance. All sources are independently verifiable and linked above. If you identify an error or have a source that should be included, contact us at yoriapp@pm.me.